ImmunoPrecise Antibodies (IPA) Institutional Ownership $0.49 -0.04 (-7.00%) As of 01/21/2025 04:00 PM Eastern Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for ImmunoPrecise Antibodies (NASDAQ:IPA)CurrentInstitutional OwnershipPercentage6.70%Number ofInstitutional Buyers(last 12 months)2TotalInstitutional Inflows(last 12 months)$627.64KNumber ofInstitutional Sellers(last 12 months)0 Get IPA Insider Trade Alerts Want to know when executives and insiders are buying or selling ImmunoPrecise Antibodies stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data IPA Institutional Buying and Selling by Quarter ImmunoPrecise Antibodies Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/15/2024Ingalls & Snyder LLC1,558,892$996K0.0%+20.3%5.407% 8/9/2024Renaissance Technologies LLC63,910$65K0.0%+70.0%0.243% 1/29/2024Ingalls & Snyder LLC1,281,305$2.19M0.1%+24.6%4.868% 11/13/2023Rathbones Group PLC14,000$26K0.0%N/A0.056% 11/2/2023Ingalls & Snyder LLC1,028,253$1.88M0.1%-3.0%4.105% 8/2/2023Bank of Montreal Can208,110$668K0.0%N/A0.831% 5/9/2023Ingalls & Snyder LLC1,058,035$2.93M0.2%+9.1%4.244% 2/1/2023Bank of Montreal Can240,980$1.25M0.0%+6.0%0.966% 1/31/2023Ingalls & Snyder LLC970,147$5.05M0.3%+0.3%3.891% 11/7/2022Gradient Capital Advisors LLC26,808$107K0.1%+34.0%0.108% Get the Latest News and Ratings for IPA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ImmunoPrecise Antibodies and its competitors with MarketBeat's FREE daily newsletter. 10/21/2022Ingalls & Snyder LLC967,090$3.86M0.2%+2.9%3.878% 8/12/2022Ikarian Capital LLC61,433$237K0.0%-20.9%0.247% 8/11/2022Bank of Montreal Can194,164$801K0.0%+38.2%0.782% 8/10/2022Cibc World Market Inc.47,427$183K0.0%N/A0.191% 5/9/2022Ingalls & Snyder LLC932,200$4.79M0.2%+13.6%4.570% 2/11/2022Ingalls & Snyder LLC820,258$4.40M0.2%+32.0%4.215% 1/31/2022Gradient Capital Advisors LLC20,000$107K0.0%-7.9%0.103% 1/24/2022National Bank of Canada FI7,540$40K0.0%N/A0.039% 11/15/2021Marshall Wace LLP175,514$1.09M0.0%+384.1%0.906% 11/12/2021Trexquant Investment LP17,852$111K0.0%N/A0.092% 11/12/2021Credit Suisse AG88,829$553K0.0%+130.0%0.459% 10/27/2021Ingalls & Snyder LLC621,447$3.87M0.2%+3.4%3.212% 8/25/2021Marshall Wace LLP36,259$218K0.0%+8.5%0.188% 8/16/2021Credit Suisse AG38,623$233K0.0%+15.6%0.200% 8/16/2021Marshall Wace LLP36,259$218K0.0%+8.5%0.188% 8/13/2021Renaissance Technologies LLC17,400$105K0.0%N/A0.090% 8/13/2021AWM Investment Company Inc.398,145$2.40M0.2%-16.7%2.070% 8/12/2021Dimensional Fund Advisors LP12,538$75K0.0%N/A0.065% 8/12/2021JPMorgan Chase & Co.68,885$1.29M0.0%+55.4%0.358% 8/12/2021Bank of Montreal Can45,224$285K0.0%+543.8%0.235% 8/5/2021Orion Portfolio Solutions LLC14,111$85K0.0%-16.3%0.073% 8/3/2021Ingalls & Snyder LLC600,810$3.62M0.2%+16.2%3.124% 5/17/2021Ikarian Capital LLC150,000$1.47M0.0%N/A0.783% 5/14/2021Credit Suisse AG33,423$328K0.0%N/A0.174% 5/13/2021AWM Investment Company Inc.478,020$4.69M0.5%N/A2.494% 5/12/2021JPMorgan Chase & Co.44,320$435K0.0%+127.2%0.231% 5/11/2021Rockefeller Capital Management L.P.3,965$38K0.0%+75.4%0.021% 4/21/2021Ingalls & Snyder LLC517,195$5.08M0.2%+30.5%2.705% 2/19/2021JPMorgan Chase & Co.19,505$292K0.0%N/A0.116% 2/17/2021Jane Street Group LLC40,774$610K0.0%N/A0.243% Did You See Trump’s Manhattan Project Bombshell? (Ad)This secret document contains stunning details about Donald Trump’s very first order of business… the minute he steps back into the White House. Because if what’s in this leaked document is even half true (and trust me, it comes from a very, very credible source)... Trump’s first Executive Order would easily be the boldest, most mind-blowing and daring American initiative ANY U.S. President has launched in over 80 years. Click here and see for yourself.2/5/2021Orion Portfolio Solutions LLC15,821$237K0.0%N/A0.094% 1/27/2021Ingalls & Snyder LLC396,425$5.93M0.3%N/A2.358% (Data available from 1/1/2016 forward) IPA Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of IPA shares? During the previous two years, the following institutional investors and hedge funds held shares of ImmunoPrecise Antibodies shares: Ingalls & Snyder LLC ($996K), Bank of Montreal Can ($668K), and Renaissance Technologies LLC ($65K), Rathbones Group PLC ($26K).Learn more on IPA's institutional investors. What percentage of ImmunoPrecise Antibodies stock is owned by institutional investors? 6.70% of ImmunoPrecise Antibodies stock is owned by institutional investors. Learn more on IPA's institutional investor holdings. Which institutional investors have been buying ImmunoPrecise Antibodies stock? The following institutional investors have purchased ImmunoPrecise Antibodies stock in the last 24 months: Ingalls & Snyder LLC ($607.45K), Bank of Montreal Can ($221.79K), Renaissance Technologies LLC ($26.31K), and Rathbones Group PLC ($14K). How much institutional buying is happening at ImmunoPrecise Antibodies? Institutional investors have bought a total of 869,549 shares in the last 24 months. This purchase volume represents approximately $1.60M in transactions. Which ImmunoPrecise Antibodies major shareholders have been selling company stock? The following institutional investors have sold ImmunoPrecise Antibodies stock in the last 24 months: Ingalls & Snyder LLC ($31.80K). How much institutional selling is happening at ImmunoPrecise Antibodies? Institutional investors have sold a total of 31,802 shares in the last 24 months. This volume of shares sold represents approximately $58.20K in transactions. Related Companies BeyondSpring Major Shareholders Reviva Pharmaceuticals Major Shareholders Mural Oncology Major Shareholders Immuneering Major Shareholders Generation Bio Major Shareholders Werewolf Therapeutics Major Shareholders Connect Biopharma Major Shareholders Eliem Therapeutics Major Shareholders NRx Pharmaceuticals Major Shareholders FibroGen Major Shareholders This page (NASDAQ:IPA) was last updated on 1/22/2025 by MarketBeat.com Staff From Our PartnersBill Gates’ is about to mint millionaires (again) with Stargate.This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredDid You See Trump’s Manhattan Project Bombshell?This secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredTrump currency shock imminentTrump's Quiet $1.9 Trillion Move Against the Fed A small army of Americans, with Trump's support, has launc...Stansberry Research | SponsoredJanuary 29th - the next big trading catalyst to watch Mark your calendar for January 29th. Because on that day, I believe we could see a $2 Trillion shock INTO t...Timothy Sykes | SponsoredElon’s #1 AI Stock” SET TO SOARForget ChatGPT! Because Elon Musk's AI promises to be 100x more powerful.Behind the Markets | SponsoredI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ImmunoPrecise Antibodies Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share ImmunoPrecise Antibodies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free IPA Stock Alerts